Task: Answer the multiple-choice question.
Question: Which drug exhibits a 14.227\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CCN1C(=O)C(CC(=O)Nc2ccccc2Cl)N(NC(=O)c2cccc(F)c2)C1=S
b) COc1cc(OC)c(C(=O)CCC(=O)O)cc1OC
Answer: a. CCN1C(=O)C(CC(=O)Nc2ccccc2Cl)N(NC(=O)c2cccc(F)c2)C1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1C(=O)C(CC(=O)Nc2ccccc2Cl)N(NC(=O)c2cccc(F)c2)C1=S
CCN1C(=O)C(CC(=O)Nc2ccccc2Cl)N(NC(=O)c2cccc(F)c2)C1=S
N-[5-[2-(2-chloroanilino)-2-oxoethyl]-3-ethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-5-fluorobenzamide